Synergy Research
Home Research Peptides Contact
Research Peptides
Home › Research Peptides › Guides › PT-141
Research guide

PT-141 research guide

A factual reference for laboratories working with PT-141: what the material is, how it is handled and stored, how to read its certificate of analysis, and how to order it in Canada. It is written for in-vitro research and makes no claims about effects in people or animals.

What is PT-141?

PT-141, also known by the non-proprietary name bremelanotide, is a synthetic cyclic heptapeptide derived from Melanotan-II. It is the carboxylic-acid form of that molecule: the sequence, N-terminal acetyl group, norleucine substitution, D-phenylalanine and the Asp-Lys lactam bridge are all retained, and only the C-terminal amide is replaced by a free acid.

That change is small on paper, one additional oxygen and one fewer nitrogen, but it alters the charge of the molecule at physiological pH and its selectivity across melanocortin receptor subtypes in binding assays. PT-141 is often described in the literature as a melanocortin receptor agonist with a preference for MC4R over MC1R.

Synergy Research supplies PT-141 as a lyophilised solid in a sealed glass vial. It is produced by solid-phase synthesis followed by cyclisation and reversed-phase purification, and each lot is tested independently for identity and purity.

Specification summary

Format
Lyophilised solid, sealed glass vial
Sizes
a 10mg vial
Molecular formula
C50H68N14O10
Molar mass
1025.2 g/mol
Residues
7 (cyclic)
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Values are taken from the product page and the public PubChem record. Each lot is confirmed against them by the independent testing reported on the certificate of analysis.

Research context

In published research PT-141 appears in receptor-binding and functional assays alongside Melanotan-II, alpha-MSH and the antagonist SHU9119, where the panel is used to map the structure-activity relationships of the melanocortin pharmacophore. Cell lines stably expressing individual human melanocortin receptors and a cAMP reporter are the usual system.

A pharmaceutical form of bremelanotide has been approved by the United States regulator for one indication; the material sold here is a research-grade reference compound, not that product, and is not approved for any use in Canada. No outcome of any study is reported or implied on this page.

Synergy Research does not evaluate, summarise or endorse the findings of any study. The material is supplied so that laboratories can design and run their own in-vitro experiments.

Storage and handling for laboratory use

Unopened vials of PT-141 should be stored sealed, in a cool, dry place away from light. Refrigeration at 2 to 8 °C is used for longer storage, and freezing at -20 °C is common practice for lyophilised material held for many months. The lyophilised solid is far more stable than any solution, so vials should remain unopened until they are needed.

Like Melanotan-II, PT-141 contains a tryptophan residue and should be protected from light. The dry solid is otherwise stable under normal refrigerated storage.

Allow a cold vial to reach room temperature before removing the cap or piercing the stopper, so that moisture from the air does not condense on the solid. Record the lot number from the label in your laboratory notebook; it is the link between the vial and its certificate.

Reconstitution in the laboratory

Lyophilised material is dissolved immediately before use in a sterile diluent appropriate to the assay. Bacteriostatic water (0.9% benzyl alcohol), sterile water for laboratory use, or a neutral buffer such as phosphate-buffered saline are common choices. The diluent is added slowly down the inside wall of the vial rather than directly onto the powder, and the vial is swirled or rolled gently until the solid dissolves.

PT-141 dissolves in sterile or bacteriostatic water with gentle swirling. The free C-terminal acid makes the peptide slightly less basic than Melanotan-II, but solubility in neutral buffers remains good at research concentrations.

The volume of diluent determines the concentration of the resulting solution; laboratories calculate it from the stated vial content and the molar mass given above. Solutions should be labelled with compound, concentration, lot number and date, kept refrigerated and protected from light, and discarded according to your own stability data. Repeated freeze-thaw cycles should be avoided; if a solution must be stored frozen, divide it into single-use aliquots first.

How to read the Certificate of Analysis

Every lot Synergy Research sells is tested by an independent Canadian laboratory, and the resulting certificate is published on the Certificates of Analysis page. A certificate has three parts worth checking before you use a vial.

  • Identity. Mass spectrometry measures the molecular mass of the material and compares it with the theoretical value. For PT-141 the mass spectrometry section should report an observed mass consistent with 1025.2 g/mol. Because Melanotan-II differs by only one mass unit, a high-resolution measurement or the HPLC retention time is used to confirm which compound is present.
  • Purity. Reversed-phase HPLC with UV detection separates the main compound from related impurities. The area of the main peak as a percentage of total peak area is reported as purity. Look for the chromatogram itself, not only the number.
  • Traceability. The lot number on the certificate should match the number printed on your vial, and the certificate should name the testing laboratory and the date of analysis.

If a certificate for your lot is not yet posted, email [email protected] with the lot number and it will be sent when the laboratory report is in.

Frequently asked questions

Is PT-141 the same as bremelanotide?

Yes. Bremelanotide is the non-proprietary name for the molecule known as PT-141. The research-grade material sold here is not the approved pharmaceutical product.

How does PT-141 differ from Melanotan-II?

Only at the C-terminus: PT-141 ends in a free carboxylic acid where Melanotan-II ends in an amide. The ring sequence and lactam bridge are identical.

How does the COA tell PT-141 from Melanotan-II?

The masses differ by about one unit (1025.2 versus 1024.2 g/mol), so the laboratory relies on accurate mass measurement together with the HPLC retention time, which differs because of the change in charge.

What size is available?

PT-141 is supplied as a 10mg lyophilised vial with a published certificate of analysis for the lot.

Is PT-141 approved for human or animal use in Canada?

No. The material sold by Synergy Research is for in-vitro laboratory research only and is not approved for any use in people or animals.

Buy PT-141 in Canada

Synergy Research supplies PT-141 as a 10mg vial. Orders ship across Canada by Canada Post Xpresspost with tracking, and payment is accepted by Interac e-Transfer or card. Every vial is matched to a published certificate of analysis.

View PT-141 product page →

See also: how to choose a research peptide supplier in Canada and the certificate archive.

For Research Use Only. Not for human or animal consumption, and not for use in diagnostic or therapeutic procedures. Nothing on this page describes, recommends or implies any use of this material in people or animals. See our Research Use Policy.

Why order from us
🚚

Fast, tracked shipping

Cold-chain protected where required, dispatched with tracking on every order.

👤

Real people, not bots

Questions answered by our team the same business day.

🧪

Research use only

For Research Use Only. Not for use in diagnostic or therapeutic procedures. Not for human or animal consumption.